Nasdaq requires listed companies to maintain a minimum bid price of $1 per share. If a company's share price falls below this threshold for a certain period, it risks being delisted. This news directly impacts Yield10 Bioscience Inc as it indicates that the company is not meeting this requirement, which could lead to its delisting from Nasdaq. This is likely to negatively impact the company's stock price in the short term.